| ISIN | CH0435830630 |
|---|---|
| Valor Number | 43583063 |
| Bloomberg Global ID | ZKBASCI SW |
| Fund Name | ZugerKB Fonds - Aktien ESG Schweiz (CHF) I |
| Fund Provider |
Zuger Kantonalbank AG, Zug
Baarerstrasse 37 6301 Zug Phone: +41 41 709 11 11 |
| Fund Provider | Zuger Kantonalbank AG, Zug |
| Representative in Switzerland | |
| Distributor(s) | Zuger Kantonalbank, Zug |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Das Anlageziel des Teilvermögens ZugerKB Fonds - Aktien Schweiz (CHF) besteht in einem langfristig möglichst hohen Anlageertrag in der Rechnungseinheit CHF. |
| Peculiarities |
| Current Price * | 162.72 CHF | 10.12.2025 |
|---|---|---|
| Previous Price * | 162.72 CHF | 09.12.2025 |
| 52 Week High * | 166.69 CHF | 03.03.2025 |
| 52 Week Low * | 138.94 CHF | 09.04.2025 |
| NAV * | 162.72 CHF | 10.12.2025 |
| Issue Price * | 162.72 CHF | 10.12.2025 |
| Redemption Price * | 162.72 CHF | 10.12.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 250,857,875 | |
| Unit/Share Assets *** | 66,165,494 | |
| Trading Information SIX | ||
| YTD Performance | +8.61% |
31.12.2024 - 10.12.2025
31.12.2024 10.12.2025 |
|---|---|---|
| 1 month | +3.07% |
10.11.2025 - 10.12.2025
10.11.2025 10.12.2025 |
| 3 months | +3.88% |
10.09.2025 - 10.12.2025
10.09.2025 10.12.2025 |
| 6 months | +1.17% |
10.06.2025 - 10.12.2025
10.06.2025 10.12.2025 |
| 1 year | +8.17% |
10.12.2024 - 10.12.2025
10.12.2024 10.12.2025 |
| 2 years | +18.20% |
11.12.2023 - 10.12.2025
11.12.2023 10.12.2025 |
| 3 years | +28.11% |
12.12.2022 - 10.12.2025
12.12.2022 10.12.2025 |
| 5 years | +37.91% |
10.12.2020 - 10.12.2025
10.12.2020 10.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 8.39% | |
|---|---|---|
| UBS Group AG Registered Shares | 8.34% | |
| Nestle SA | 7.89% | |
| Lonza Group Ltd | 7.03% | |
| Novartis AG Registered Shares | 6.72% | |
| Zurich Insurance Group AG | 5.52% | |
| Swiss Life Holding AG | 4.49% | |
| ABB Ltd | 4.24% | |
| Alcon Inc | 3.81% | |
| Swiss Re AG | 3.74% | |
| Last data update | 31.08.2025 | |
| TER | 0.65% |
|---|---|
| TER date | 31.05.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.60% |
| Ongoing Charges *** | 0.67% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |